SCHEMBL4209392

SCHEMBL4209392

CC(N)(N)N1CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8130428 0.97 CYP2B6 (0.39)
SCHEMBL3593852 0.80
SCHEMBL4702119 0.78 CYP2B6 (0.39)
SCHEMBL21469894 0.73
SCHEMBL30413234 0.73 CYP2B6 (0.37)
SCHEMBL467885 0.73 ADRB1 (0.31)
SCHEMBL5815726 0.73 SMN1; SMN2 (0.34)
SCHEMBL22756187 0.72 CYP2B6 (0.39)
SCHEMBL179261 0.72
SCHEMBL4915083 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023212652-A1 HIGH PURITY LIGAND-AL-HYDRIDE COMPOSITIONS IMPACT NANO LLC (US) 2023-11-02 WO disclosed
EP-1263720-B1 AZETIDINE DERIVATIVES, PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AVENTIS PHARMA SA (FR) 2009-06-03 EP disclosed
EP-1263720-A1 AZETIDINE DERIVATIVES, PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME Aventis Pharma S.A. (FR) 2002-12-11 EP disclosed
WO-2001064632-A1 AZETIDINE DERIVATIVES, PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AVENTIS PHARMA S.A. (FR) 2001-09-07 WO disclosed